GleamWall
中文EN

STAA STAAR SURGICAL CO

Ophthalmic Goods · Nasdaq · SEC CIK 718937 · Fiscal year ends 01/02

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY42.4%
TTM net income YoY100.5%
TTM EPS YoY100.5%
Revenue 3-yr CAGR1.9%
Net income 3-yr CAGR-69.9%

Margins

Gross margin73.6%
Operating margin0.2%
Net margin0.2%
FCF margin5.4%
EBITDA margin2.9%

Returns

ROE0.1%
ROA0.1%
ROIC (approx.)0.2%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets22.5%
Debt / equity0.00x
Current ratio4.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income40.37x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-10-022026Q22026-07-032026Q12026-04-032025Q4*2026-01-022025Q32025-09-262025Q22025-06-272025Q12025-03-282024Q4*2024-12-27
Income statement
Revenue$83.41M$93.53M$93.52M$57.80M$94.73M$44.32M$42.59M$48.95M
Cost of revenue$24.28M$23.81M$24.66M$14.06M$16.86M$11.52M$14.58M$17.30M
Gross profit$59.13M$69.73M$68.86M$43.74M$77.88M$32.80M$28.00M$31.65M
R&D expense$10.46M$9.94M$9.93M$9.24M$9.21M$10.26M$11.34M$9.77M
SG&A expense$53.68M$59.63M$60.88M$66.58M$59.38M$62.76M$85.41M$59.56M
Operating income$5.46M$10.10M$7.98M-$22.84M$18.49M-$29.96M-$57.40M-$27.91M
Pretax income$6.98M$11.02M$8.22M-$20.65M$18.79M-$25.91M-$54.49M-$30.33M
Income tax$1.41M$2.97M$3.01M-$2.34M$9.91M-$9.10M-$275,000$3.89M
Net income$5.58M$8.06M$5.21M-$18.31M$8.88M-$16.81M-$54.21M-$34.23M
EBITDA$7.89M$12.49M$10.09M-$20.83M$20.49M-$27.99M-$55.06M-$25.54M
EPS (basic)0.110.160.10—0.18-0.34-1.10—
EPS (diluted)0.110.160.10—0.18-0.34-1.10—
Weighted avg. shares (diluted)51.45M51.50M50.90M—50.55M49.52M49.34M—
Balance sheet
Cash & equivalents$133.61M$148.58M$131.86M$153.15M$176.16M$167.13M$173.11M$144.16M
Short-term investments$72.80M$32.91M$32.02M$34.39M$16.50M$22.75M$49.65M$86.33M
Receivables$86.53M$98.47M$81.17M$50.06M$60.10M$34.44M$39.95M$77.90M
Inventory$48.58M$49.53M$52.66M$58.42M$55.09M$55.16M$50.50M$44.58M
Current assets$353.43M$342.35M$312.40M$311.55M$321.21M$292.79M$326.50M$367.94M
PP&E, net$68.53M$69.93M$71.74M$73.32M$72.61M$74.42M$74.96M$84.89M
Goodwill$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M
Total assets$485.16M$475.20M$451.12M$451.68M$456.36M$437.78M$457.36M$509.52M
Current liabilities$75.54M$73.39M$60.99M$68.50M$61.64M$59.23M$68.36M$70.31M
Total liabilities$109.03M$109.81M$98.75M$107.49M$102.58M$101.21M$107.39M$112.19M
Shareholders' equity$376.13M$365.40M$352.37M$344.18M$353.78M$336.57M$349.97M$397.33M
Shares outstanding50.20M50.12M49.78M49.40M49.73M49.55M49.52M49.29M
Cash flow statement
Operating cash flow$27.32M$19.69M-$21.70M-$3.91M$2.67M-$27.25M-$5.73M$642,000
Capital expenditure$935,000$494,000$443,000$1.68M$883,000$1.79M$1.47M$5.72M
Free cash flow$26.38M$19.20M-$22.14M-$5.59M$1.78M-$29.04M-$7.20M-$5.08M
Investing cash flow-$40.67M-$1.37M$2.15M-$19.41M$5.28M$25.12M$35.35M-$19.50M
Financing cash flow-$1.32M-$1.50M-$1.69M-$50,000$983,000-$4.54M-$948,000-$110,000
Depreciation & amortization$2.43M$2.39M$2.11M$2.01M$2.00M$1.98M$2.34M$2.38M
Stock-based compensation$5.52M$6.56M$4.82M$8.61M$8.16M$7.80M$6.01M$4.67M
Share buybacks———$0$1.98M———

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.